NCT02404155View on ClinicalTrials.gov

Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN)

NACompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

October 26, 2021

Study Completion Date

October 26, 2021

Conditions
Schizophrenia
Interventions
DRUG

Clozapine

Trial Locations (1)

21228

Maryland Psychiatric Research Center, Catonsville

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT02404155 - Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN) | Biotech Hunter | Biotech Hunter